Publications

Publications, Books, Book Chapters and Reviews by Prof. Marcus Maurer, MD

Use: Start with an overview of all publications. Use tag links to list selected documents or to list an entire category, e.g. Original Work, Books, Book Chapters, Reviews. If you know what you are looking for, enter this term in the search field.

Anti-IL-23 treatment with tildrakizumab can be effective in omalizumab-refractory chronic spontaneous urticaria – a case series

Filename 553. Bonnekoh et al., Anti-IL-23 treatm. tildrakizumab CSU, JACIPract 2023.pdf
Filesize 237.53 KB
Version o.553
Date added December 14, 2023
Downloaded 0 times
Category Original Work
Authors Bonnekoh, H., Kiefer, L., Buttgereit, T., Kolkhir, P., Lütke-Eversloh, M., Scheffel, J., Maurer, M., and Metz, M.
Citation Bonnekoh, H., Kiefer, L., Buttgereit, T., Kolkhir, P., Lütke-Eversloh, M., Scheffel, J., Maurer, M., and Metz, M.: Anti-IL-23 treatment with tildrakizumab can be effective in omalizumab-refractory chronic spontaneous urticaria – a case series. J. Allergy Clin. Immunol. Pract. 2023: 11; 2578-2580.
Corresponding authors Metz, M.
DocNum o.553
DocType PDF
IF TBD (IF 2022: 9.40)
Publisher J. Allergy Clin. Immunol. Pract.
ReleaseDate 2023
 

(Last update: 12.2023)

Number of original publications in peer-reviewed journals:580
Number of reviews in peer-reviewed journals:210
Number of publications (original work and reviews) in peer-reviewed journals:790
Cumulative IF for original publications in peer-reviewed journals:4196.39
Cumulative IF for reviews in peer-reviewed journals:1409.32
Cumulative IF of publications (original work & reviews) in peer-reviewed journals:5605.71
Total number of citations: 36,836, h-index: 99 (Web of Science December 2023)36836

Download-Information

To be able to download the offered contents, you have to login. If you do not know the login, please write me your request.